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ABSTRACT
Objective: A simple, rapid high-performance liquid chromatography–mass spectrometry (MS)/MS method was developed for the determination of 
bisoprolol from confluent Caco-2 monolayers and from aqueous solution.
Methods: Chromatography was achieved on discovery C 18, 50 mm×2.1 mm, 5 µm column. Samples were chromatographed in a gradient mode 
(eluent A [acetonitrile:water:formic acid, 5:95:0.1 v/v] and eluent B [acetonitrile:formic acid, 100:0.1 v/v]). The initial content of the eluent B is 0%, 
which increases linearly by 1.0 min to 100% and to 1.01 min returns to the initial 0%. The mobile phase was delivered at a flow rate of 0.400 ml/min 
into the mass spectrometer ESI chamber. The sample volume was 5 µl.
Results: Under these conditions, bisoprolol was eluted at 1.49 min. According to the Caco-2 test results, bisoprolol appeared to have moderate to high 
permeability. It should be noted that the recovery value for bisoprolol is 97.69%. Caco-2 permeability values for bisoprolol are in agreement with BCS 
Class I classification for these drugs and their known high bioavailability in humans.
Conclusion: From results of analysis, it can be concluded that developed method is simple and rapid for the determination of bisoprolol from confluent 
Caco-2 monolayers and from aqueous solution. Acquired results demonstrate that proposed strategy can be effortlessly and advantageously applied 
for the examination of bisoprolol from Caco-2 cell monolayers.
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INTRODUCTION
The Caco-2 monolayers are used as an in vitro model to predict drug 
absorption in humans and to explore mechanism of drug absorption. 
The Caco-2 cells are derived from a human colon adenocarcinoma and 
spontaneously differentiate to form confluent monolayer of polarized 
cells structurally and functionally resembling the small intestinal 
epithelium [1].
Bisoprolol fumarate can be determined by various methods such as 
ultraviolet, reverse-phase high-performance liquid chromatography 
(HPLC), LC–mass spectrometry (MS)/MS, and high-performance thin-
layer chromatography. There is an HPLC method described for the 
determination of bisoprolol (Fig. 1) in pharmaceutical preparations. In 
addition, there are another methods reported for the determination of 
bisoprolol in human plasma [2-5].
However, both methods are not developed for the examination of 
bisoprolol from Caco-2 cell monolayers. Therefore, the aim of this study 
was to develop and validate an efficient HPLC MS/MS method for the 
determination of bisoprolol from Caco-2 cell monolayers.
METHODS
Chemicals and reagents
Trypsin ethylenediaminetetraacetic acid (EDTA) (10×) 0.5%/0.2% in 
Dulbecco’s phosphate-buffered saline (DPBS) (PAA, UK; Cat# L11-003)
HEPES, high purity grade (Helicon, Am-0485)
DPBS (1×) without Ca & Mg (PAA, UK; Cat# H15-002)
Hanks’ BSS (1×) without Ca & Mg without Phenol Red (PAA, UK; Cat# 
H15-009)
DMSO Chromasolv Plus, HPLC grade, ≥99.7% (Sigma-Aldrich, USA; Cat 
#34869)
DMEM (4.5 g/l) liquid without L-glutamine (PAA, UK; Cat# E15-009)
L-glutamine (200 mM) (PAA, UK; Cat# M11-004)
Fetal Bovine Serum “GOLD” EU approved (PAA, UK; Cat# A15-151)
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Fig. 1: The chemical structures of bisoprolol fumarate
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Penicillin/streptomycin (100×) (PAA, UK; Cat# P11-010)
Acetonitrile Chromasolv, Gradient grade, For Hplc, ≥99.9% (Sigma-
Aldrich, USA; Cat #34851)
Formic acid for mass spectrometry, ~98% (Fluka, USA; Cat #94318)
Falcon® HTS 24-Multiwell Insert Systems with Media Feeder Tray (BD 
Biosciences, USA; Prod# 351181)
Falcon® 24 Well TC-treated Cell PS Permeable Support Companion 
Plate (BD, Prod# 353504)
Centrifuge tubes, 50 ml (Santa Cruz, USA; Cat# sc-200251)
Serological pipettes 5 ml, 10 ml, 25 ml (Greiner Bio-One)
Disposable pipette tips (Thermo Scientific, Fisherbrand, Eppendorf USA)
1.1 ml microtubes in microracks (Thermo Scientific, USA)
Zorbax eclipse plus C18 column 2.1×50 mm, 3.5 µm (Agilent 
Technologies, Inc. USA)
Propranolol hydrochloride ≥99% (TLC), powder (Sigma-Aldrich, USA; 
Cat # P0884)
Quinidine anhydrous (Sigma-Aldrich, USA; Cat # Q3625 Lot #BCBF1345V)
Atenolol, analytical reference material, ≥98.5% (HPLC) (Sigma-Aldrich, 
USA; Cat #74827)
Test compound was provided as dry powder (salt form bisoprolol 
fumarate) and was dissolved in DMSO at 10 mM to prepare working stocks.
Instrumentation and chromatographic conditions
All measurements were performed using Shimadzu VP HPLC system 
including vacuum degasser, gradient pumps, reverse-phase HPLC 
column, column oven, and autosampler. The HPLC system was coupled 
with tandem mass spectrometer API 3000 (PE Sciex). The TurboIon 
Spray ion source was used in both positive and negative ion modes. 
Parameters of electrospray ionizer and multiple reaction monitoring 
(MRM) parameters are listed in Tables 1 and 2. Acquisition and analysis 
of the data were performed using analyst 1.5.2 software (PE Sciex). 
Chromatography was achieved on Discovery C18, 50 mm×2.1 mm, 
5 µm column. Samples were chromatographed in a gradient mode 
(eluent A [acetonitrile:water:formic acid, 5:95:0.1 v/v] and eluent B 
[acetonitrile:formic acid, 100:0.1 v/v]). The initial content of the eluent 
B is 0%, which increases linearly by 1.0 min to 100% and to 1.01 min 
returns to the initial 0%. The mobile phase was delivered at a flow rate 
of 0.400 ml/min into the mass spectrometer ESI chamber. The sample 
volume was 5 µl.
Caco-2 cells were cultivated in 75 cm2 flasks to 70–80% of confluence 
according to the ATCC and Millipore recommendations [6] in 
humidified atmosphere at 37°C and 5% CO2. Cells were detached with 
trypsin/EDTA solution and resuspended in the cell culture medium to 
a final concentration of 2×105 cells/ml. 500 µl of the cell suspension 
was added to each well of HTS 24-multiwell insert system and 35 ml 
of prewarmed complete medium was added to the feeder tray. Caco-
2 cells were incubated in Multiwell Insert System for 21 days before 
the transport experiments. The medium in filter plate and feeder tray 
was changed every other day. After 21 days of cell growth, the integrity 
of the monolayer was verified by measuring the transepithelial 
electrical resistance (TEER) for every well using the Millicell-ERS 
system ohm meter. The final TEER values were within the range 
of 150–600 Ω×cm2 [7] as required for the assay conditions. 24-well 
insert plate was removed from its feeder plate and placed in a new 
sterile 24-well transport analysis plate. The medium was aspirated and 
inserts washed with PBS twice.
To determine the rate of compounds transport in apical (A) to 
basolateral (B) direction, 300 µL of the test compound dissolved in 
transport buffer at 10 µM (HBSS, 10 mM HEPES, pH=7.4) was added 
into the filter wells; 1000 µL of buffer (HBSS, 10 mM HEPES, pH=7.4) 
was added to transport analysis plate wells. The plates were incubated 
for 90 min at 37°C with shaking at 100 RPM. 75 µL aliquots were taken 
from the donor and receiver compartments for LC–MS/MS analysis. All 
samples were mixed with two volumes of acetonitrile with following 
protein sedimentation by centrifuging at 10,000 rpm for 10 min. 
Supernatants were analyzed using the HPLC system coupled with 
tandem mass spectrometer.
Table 1: Parameters of ionizer electrospray
S. no Parameter Value
1 Polarity Positive
2 Nebulizer gas (NEB, gas 1) 15
3 Curtain gas (CUR) 8
4 Collision gas (CAD) 4
5 Ion Spray voltage (IS) 5000
6 Temperature (TEM) 400
7 TurboIon Spray gas 8
8 Horizontal position 5.3
9 Lateral position 1.3
Table 2: MRM parameters
Compound ID Parent, m/z Daughter, m/z Time, ms DP, V FP, V EP, V CE, V CXP, V
Bisoprolol 326.435 116.3 50 46 260 11 27 20
DP: Declustering potential, FP: Focusing potential, EP: Entrance potential, CE: Collision energy, CXP: Collision cell exit potential, MRM: Multiple reaction monitoring
Table 3: Optimized chromatographic conditions
Parameter Chromatographic conditions
Instrument Shimadzu HT (Shimadzu, Japan) LC system equipped with degasser (DGU-14A), binary pump (LC-20ADXR) along 
with autosampler (SIL-20ACXR)
Column Discovery C 18, 50 mm×2.1 mm, 5 µm
Mobile phase Gradient mode (eluent A [acetonitrile: water: formic acid, 5:95:0.1 v/v] and eluent B [acetonitrile: formic acid, 
100:0.1 v/v]). The initial content of the eluent B is 0%, which increases linearly by 1.0 min to 100% and to 1.01 min 
returns to the initial 0%
Flow rate 0.400 ml/min
Runtime 5 min
Column temperature 30°C
Volume of injection loop 5 µl
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Fig. 3: Typical multiple reaction monitoring chromatograms of bisoprolol
Propranolol (high permeability), atenolol (low permeability), and 
quinidine (moderate permeability) were used as reference compounds.
The apparent permeability (Papp) was calculated for Caco-2 permeability 














VA – volume of transport buffer in acceptor well,
Area – surface area of the insert (equals to effective growth area of the 
insert - 0.31 cm2),
Time – time of the assay,
[drug]acc – concentration of test compound in acceptor well,
[drug]initial,d – initial concentration of test compound in a donor well.
Papp is expressed in 10−6 cm/s.
The % recovery can be useful in interpreting the Caco-2 data. If the 
recovery is very low, this may indicate problems with poor solubility, 
binding of the compound to the test plate materials, metabolism Fig. 2: Gradient curve
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by the Caco-2 cells, or accumulation of the compound in the cell 
monolayer. The % recovery was calculated using the following 
equation:
acc acc d d
initial, d d
C V C V





Vacc – volume of compound solution in acceptor well (cm2),
Vd – volume of compound solution in donor well (cm2),
Cacc – concentration of test compound in acceptor well (µM),
Cinitial,d – initial concentration of test compound in a donor well (µM).
RESULTS AND DISCUSSION
In the present study, optimization and critical evaluation of mobile phase 
composition (gradient), flow rate, and analytical column were important 
to obtain good resolution of peaks of interest from the endogenous 
components, which in turn affect reproducibility and sensitivity of the 
method [8-10]. The resolution of peaks was best achieved with discovery 
C 18, 50 mm×2.1 mm, 5 µm column. Samples were chromatographed in 
a gradient mode (eluent A [acetonitrile:water:formic acid, 5:95:0.1 v/v] 
and eluent B [acetonitrile:formic acid, 100:0.1 v/v]). The initial content 
of the eluent B is 0%, which increases linearly by 1.0 min to 100% and 
to 1.01 min returns to the initial 0%. Gradient curve was shown in 
Fig. 2. The mobile phase was delivered at a flow rate of 0.400 ml/min 
into the mass spectrometer ESI chamber. The injection volume was 
5 µl. The optimum chromatographic conditions and system suitability 
parameters are tabulated in Table 3.
Each value is represented as a mean ± SD of five observations (n=5), 
SD: Standard deviation, RSD: Relative standard deviation, #Acceptance 
criteria<2.0.
Bisoprolol eluted at ~1.49 min. Typical MRM chromatograms of 
bisoprolol are shown in Fig. 3. A-B permeability data for the test 
compound of bisoprolol fumarate and three reference compounds are 
listed in Table 4. A-B permeability data for all the reference compounds 
correspond to the literature data, thus validating this study [11-13]. 
According to the Caco-2 test results, bisoprolol appeared to have 
moderate to high permeability.
It should be noted that the recovery value (Table 5) for bisoprolol is 
97.69%. Caco-2 permeability values for bisoprolol are in agreement 
with BCS Class I classification for these drugs and their known high 
bioavailability in humans [14-17].
CONCLUSION
From results of analysis, it can be concluded that developed method is 
simple and rapid for the determination of bisoprolol from confluent Caco-
2 monolayers and from aqueous solution. Acquired results demonstrate 
that proposed strategy can be effortlessly and advantageously applied 
for the examination of bisoprolol from Caco-2 cell monolayers.
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Table 4: Data of A‑B permeability for the test and reference 
compounds (at 10 µM)
Compound ID Permeability (10−6 cm/s) SD (10−6 )
1 2 3 Mean
Atenolol 1.83 1.99 1.48 1.77 0.26
Propranolol 37.50 35.20 35.70 36.13 1.21
Quinidine 16.50 23.80 20.00 20.10 3.65
Bisoprolol 14.40 16.10 15.70 15.40 0.89
Each value is represented as a mean±SD of five observations (n=5), 
SD: Standard deviation, RSD: Relative standard deviation, #Acceptance 
criteria<2.0
Table 5: Recovery values
Compound ID % recovery
1 2 3 Mean
Atenolol 109.61 99.70 101.90 103.74
Propranolol 112.78 97.86 97.50 102.71
Quinidine 96.49 102.59 97.68 98.92
Bisoprolol 91.78 104.48 96.82 97.69
